Main Management ETF Advisors’s CARGO Therapeutics CRGX Stock Holding History

Main Management ETF Advisors’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-65,216	Closed	-$269K	–	142
2025 Q2	$269K	Buy	65,216 +1,056	+2%	+$4.52K	0.01%	134
2025 Q1	$261K	Buy	+64,160	New	+$430K	0.01%	137

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Main Management ETF Advisors's CRGX Position: Q3 2025 in Review

Main Management ETF Advisors sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 65,216 shares — an estimated $269K sold.

Main Management ETF Advisors first reported a position in CRGX in Q1 2025 and held it in 2 quarters. The position peaked at $269K in Q2 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Main Management ETF Advisors reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Main Management ETF Advisors sold 65,216 CARGO Therapeutics shares in Q3 2025, an estimated $269K.
Main Management ETF Advisors first reported a position in CARGO Therapeutics in Q1 2025 and held it in 2 quarters.
Main Management ETF Advisors's CARGO Therapeutics position peaked at $269K in Q2 2025.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Main Management ETF Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.